58 results
8-K
EX-10.2
PYXS
Pyxis Oncology Inc
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or governmental … remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified Person and shall survive the transfer
8-K
EX-10.1
3oogyvcjdux9aggihv
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-4.1
1ki75boantzr
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-10.1
zfhuljoib8jl rid
28 Nov 23
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
7:22am
S-8 POS
EX-5.1
ansokb
23 Aug 23
Registration of securities for employees (post-effective amendment)
5:30pm
POS AM
EX-5.1
grj9o
23 Aug 23
Prospectus update (post-effective amendment)
5:28pm
S-8
EX-5.1
7fak1txtszaj5n2 mt
23 Aug 23
Registration of securities for employees
5:28pm
424B3
c9j25
30 Jun 23
Prospectus supplement
4:05pm
S-4/A
EX-5.1
fp3y69vb 71k46kjt
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4/A
3fi3gow
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
udrgb38j
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
zx6gg0zaby3sql z1q
24 May 23
Business combination disclosure
7:05am
425
8b043mq9 wexj
24 May 23
Business combination disclosure
7:03am
8-K
EX-10.1
3bmpgi0s08yty
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am